Skip to main content

Quanome Technologies, Inc.

corporate_fare Company Profile

Quanome Technologies, Inc.

QNME·NASDAQ·Energy & Transportation·CIK 0001996192

Quanome Technologies, Inc. operates in three main business areas. First, it has established, revenue-generating pharmaceutical distribution operations through its subsidiary, Hupan Pharmaceutical. This segment primarily sells infusion products, foods for special medical purposes, and specialty pharmaceuticals to hospitals, pharmaceutical distributors, and other healthcare providers. Second, the company has a recently initiated strategic focus on quantum-related and certain other advanced technology activities. This area is currently in the development and evaluation stage and has not generated revenue as of the date of this report. Third, Quanome Technologies, Inc. has recently started efforts to provide dedicated AI compute capacity and managed inference services. These efforts are in the preliminary stage and have not resulted in executed customer contracts or generated revenue as of the date of this report. Prior to February 12, 2026, the company also operated as a U.S.-based integrated cross-border supply chain solutions provider focused on the Asian market, in addition to its pharmaceutical distribution. On February 12, 2026, the operations of ABL Chicago were transferred to an unrelated third party, and the company ceased substantive involvement in ABL Chicago's cross-border freight forwarding and logistics business. The company is evaluating opportunities to reposition its business from traditional pharmaceutical distribution toward quantum-related technologies and applications, including quantum computing, artificial intelligence, advanced simulation, and intelligent systems, through its subsidiary, Quantum Nexus. Quantum Nexus is evaluating and developing computational capabilities with potential applications in therapeutic discovery, healthcare, advanced materials, energy, and cybersecurity. The company may also pursue collaborations, acquisitions, or other strategic transactions in these fields.

Quanome Technologies, Inc. (NASDAQ:QNME) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 10 items for QNME at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for QNME spans 10-Q, 8-K, 424B5, 10-K.

Recent high-impact activity:

  • Quanome Q1 Revenue Jumps 53% but Going-Concern Warning Persists
  • Quanome to Issue 6.54M Shares (~16% Dilution) for 5% Stake in QAI Labs
  • Quanome Dilutes 16% to Buy 5% of Pre-Commercial QAI Labs
  • Quanome's XDT Unit Collects $13.5M Prepayment on $100M+ AI Inference Order
  • Quanome Launches $9.75M ATM With Maxim at $0.474, ~60% of Shares Outstanding

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$17.79M
Net Income
-$5.25M
Diluted EPS
-$0.69
Op. Cash Flow
-$2.66M
Free Cash Flow
-$2.7M
Gross Profit
$2.88M
Operating Income
-$4.96M
Cash & Equivalents
$4.96M
Total Debt
$1.36M
Debt / Equity
0.48×
Net Margin
-29.5%
Shares Outstanding
10.5M sh
Source: 10-K · filed 2025-10-14 · accession 0001213900-25-098720

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,287,260 shares in QNME as of the October 30, 2026 settlement, a 54.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 24.5% of QNME volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,287,260 shares as of October 30, 2026
Change vs prior period▲ 54.8%
Days to cover1.00 at avg daily volume of 1,977,989
Daily short volume (FINRA facilities)24.5% of 45,532 shares on November 20, 2026
5-day average short volume31.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for QNME, detected from its recent SEC filings · based on capital-structure filings through 2026-10-21.

1 recent capital raiseATM program1 shelf registration

ATM Program Sized at $9.75M · Roughly 60% of Shares Outstanding

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with Q →
$0.24 -0.41% today
52-week range · as of 2026-11-16 $0.24 – $1.4
Market cap
$8.3M
Volume
108.6K (0.1× avg)
3-mo avg 989.8K
Live data · 2026-11-22 06:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed QNME - Latest Insights

QNME
Nov 16, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.330
Real-time Price: $0.240 info
Change: -$0.090 (-27%) info
Market Cap: $8.297M info
QNME
Nov 09, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.400
Real-time Price: $0.240 info
Change: -$0.160 (-40%) info
Market Cap: $8.297M info
QNME
Nov 09, 2026, 8:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3755
Real-time Price: $0.240 info
Change: -$0.1355 (-36%) info
Market Cap: $8.297M info
QNME
Oct 29, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.4915
Real-time Price: $0.240 info
Change: -$0.2515 (-51%) info
Market Cap: $8.297M info
QNME
Oct 21, 2026, 4:05 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $0.4807
Real-time Price: $0.240 info
Change: -$0.2407 (-50%) info
Market Cap: $8.297M info
QNME
Oct 05, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Updated Oct 8, 2:42 PM ET — XDT's initial order has a 60-month term and total commitment value exceeding $100 million, with service expected to commence within approxi…
Price at Filing: $0.575
Real-time Price: $0.240 info
Change: -$0.335 (-58%) info
Market Cap: $8.297M info
QNME
Oct 01, 2026, 9:25 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.5818
Real-time Price: $0.240 info
Change: -$0.3418 (-59%) info
Market Cap: $8.297M info
QNME
Sep 25, 2026, 4:46 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.7499
Real-time Price: $0.240 info
Change: -$0.5099 (-68%) info
Market Cap: $8.297M info
QNME
Sep 23, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.960
Real-time Price: $0.240 info
Change: -$0.720 (-75%) info
Market Cap: $8.297M info
QNME
Sep 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6018
Real-time Price: $0.240 info
Change: -$0.3618 (-60%) info
Market Cap: $8.297M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets